GlassScriptPhysician profile
Monica Reicks
NPI 1538394291
$6,525.12
in general payments reported to CMS, 2019-2025
49 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,105 · 2020: $871 · 2021: $959 · 2022: $701 · 2023: $1,108 · 2024: $1,297 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,888.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,013.63 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $981.22 | 2021-2025 | |
| Pfizer INC. | $550.26 | 2019-2025 | |
| Lilly USA, LLC | $448.36 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $434.41 | 2019-2025 | Airsupra, Farxiga |
| Amgen INC. | $386.34 | 2019-2025 | Evenity, Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $317.36 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $198.88 | 2019-2024 | Trintellix |
| Novartis Pharmaceuticals Corporation | $198.46 | 2019-2025 | |
| Dexcom, INC. | $157.20 | 2022-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $148.70 | 2019-2022 | |
| Glaxosmithkline, LLC. | $132.71 | 2019-2024 | Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $131.51 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $117.21 | 2019-2023 | Livalo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.80 | 2019-2025 | Jardiance |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Reicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.